Singapore - Export of Heparin for Therapeutic Use
Since 2014, Singapore Export of Heparin for Therapeutic Use fell by 10.3% year on year. With $425,870,600.82 in 2019, the country was ranked number 4 comparing other countries in Export of Heparin for Therapeutic Use. Singapore is overtaken by France, which was ranked number 3 at $438,317,784.64 and is followed by Ireland at $193,558,300.78. China lead the ranking with $1,237,456,257.9 in 2019, -3% compared to 2018. Montenegro recorded the best 5 years average growth at +490.8% per year, while Greenland witnessed the worst performance at -78.9% per year.
Loading...
| Date | US Dollars |
|---|---|
| 2019 | 425,870,600.82 |
| 2018 | 478,432,032.00 |
| 2017 | 328,692,992.00 |
| 2016 | 366,614,688.00 |
| 2015 | 521,643,520.00 |
Download all data from 1989 to 2019
How does Singapore rank in Export of Heparin for Therapeutic Use?
| # | 108 Countries | US Dollars | Last | YoY | 5‑years CAGR | |
|---|---|---|---|---|---|---|
| 1 |
#1
China
|
1,237,456,257.90 | 2019 | -3.0 % | +6.7 % | View data |
| 2 |
#2
United States
|
528,184,315.05 | 2019 | +3.8 % | -15.3 % | View data |
| 3 |
#3
France
|
438,317,784.64 | 2019 | -7.7 % | -7.0 % | View data |
| 4 |
#4
Singapore
|
425,870,600.82 | 2019 | -11.0 % | -10.3 % | View data |
| 5 |
#5
Ireland
|
193,558,300.78 | 2019 | -10.3 % | -0.9 % | View data |